1. Home
  2. MRUS vs PATK Comparison

MRUS vs PATK Comparison

Compare MRUS & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • PATK
  • Stock Information
  • Founded
  • MRUS 2003
  • PATK 1959
  • Country
  • MRUS Netherlands
  • PATK United States
  • Employees
  • MRUS N/A
  • PATK N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • PATK Auto Parts:O.E.M.
  • Sector
  • MRUS Health Care
  • PATK Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • PATK Nasdaq
  • Market Cap
  • MRUS 2.8B
  • PATK 3.2B
  • IPO Year
  • MRUS 2016
  • PATK N/A
  • Fundamental
  • Price
  • MRUS $47.37
  • PATK $90.18
  • Analyst Decision
  • MRUS Strong Buy
  • PATK Strong Buy
  • Analyst Count
  • MRUS 13
  • PATK 9
  • Target Price
  • MRUS $85.67
  • PATK $102.07
  • AVG Volume (30 Days)
  • MRUS 513.2K
  • PATK 361.5K
  • Earning Date
  • MRUS 02-26-2025
  • PATK 02-06-2025
  • Dividend Yield
  • MRUS N/A
  • PATK 2.13%
  • EPS Growth
  • MRUS N/A
  • PATK N/A
  • EPS
  • MRUS N/A
  • PATK 4.11
  • Revenue
  • MRUS $35,932,000.00
  • PATK $3,715,683,000.00
  • Revenue This Year
  • MRUS N/A
  • PATK $8.30
  • Revenue Next Year
  • MRUS $42.15
  • PATK $6.51
  • P/E Ratio
  • MRUS N/A
  • PATK $21.90
  • Revenue Growth
  • MRUS N/A
  • PATK 7.14
  • 52 Week Low
  • MRUS $37.77
  • PATK $67.72
  • 52 Week High
  • MRUS $61.61
  • PATK $98.90
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 71.36
  • PATK 41.41
  • Support Level
  • MRUS $39.67
  • PATK $90.85
  • Resistance Level
  • MRUS $41.15
  • PATK $96.51
  • Average True Range (ATR)
  • MRUS 1.71
  • PATK 2.72
  • MACD
  • MRUS 0.86
  • PATK -0.74
  • Stochastic Oscillator
  • MRUS 91.57
  • PATK 3.66

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: